Arbutus Biopharma Corp

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.01

-0.06 (-1.18%)

As of Sep 20, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +923.0% upside

Low Target $34.47

Average Target $51.25

High Target $59.24

Current Price $5.01

Current
$5.01

Target
$51.25

$34.47 $51.25 avg $59.24

Scenario Analysis

Bear Case

$34.47

588.0%

Low target

Base Case

$51.25

+923.0%

Avg target

Bull Case

$59.24

+1,082.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.45

-8.1% from high

52-Week Low

$3.50

+43.1% from low

Target vs 52W High

$51.25

+840.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%